UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency): RNA and DNA analysis

The Journal of clinical investigation, 1987, Vol.79 (1), p.275-281

1987

Volltextzugriff (PDF)

Molecular heterogeneity of McArdle disease

Journal of inherited metabolic disease, 1986-06, Vol.9 (S2), p.287-290

1986

Volltextzugriff (PDF)

Modifications of aldolase during in vivo aging of rabbit red cells

Biochimie, 1979, Vol.61 (1), p.79-85

1979

Volltextzugriff (PDF)

Characterization of three optional promoters in the 5′ region of the human aldolase A gene

Journal of molecular biology, 1987-10, Vol.197 (3), p.425-438

1987

Volltextzugriff (PDF)

Purification of aldolase C from rat brain and hepatoma

European journal of biochemistry, 1977-07, Vol.77 (1), p.37-43

1977

Volltextzugriff (PDF)

Demonstration of aldolase immunologic cross reaction material (CRM) in rabbit erythrocyte and reticulocyte hemolysates

Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1970-02, Vol.207 (5), p.742

Mennecier, F

1970

Volltextzugriff (PDF)

Expression of aldolase a messenger RNAs in human adult and foetal tissues and in hepatoma

Biochemical and biophysical research communications, 1986-02, Vol.134 (3), p.1093-1100

1986

Volltextzugriff (PDF)

Expression of two aldolase A mRNA species in different human and rat tissues

Biochemical Society transactions, 1986-08, Vol.14 (4), p.718-719

1986

Volltextzugriff (PDF)

Phosphofructokinases from foetal and adult human muscles

Biochemical Society transactions, 1981-04, Vol.9 (2), p.357-357P

1981

Volltextzugriff (PDF)

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Annals of oncology, 2019-12, Vol.30 (12), p.1985-1991

2019

Volltextzugriff (PDF)

Modifications de l' aldolase pendant le vieillissement in vivo des globules rouges du lapin

Biochimie, 1979, Vol.61

1979

Volltextzugriff (PDF)

Molecular aging of fructose-bisphosphate aldolase in tissues of rabbit and man

Biochimica et biophysica acta, 1974-10, Vol.364 (2), p.320

1974

Volltextzugriff (PDF)

Molecular aging of fructose-bisphosphate adolase in tissues of rabbit and man

BBA - Enzymology, 1974-10, Vol.364 (2), p.320-326

1974

Volltextzugriff (PDF)

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

The lancet HIV, 2017-09, Vol.4 (9), p.e402-e410

2017

Volltextzugriff (PDF)

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Annals of oncology, 2019-12, Vol.30 (12), p.1985-1991

2019

Volltextzugriff (PDF)

1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)

Annals of oncology, 2023-10, Vol.34, p.S786-S786

2023

Volltextzugriff (PDF)

CN15 Real-life clinical and organizational evaluation of telemonitoring and assisted telemonitoring in more than 1500 cancer patients

Annals of oncology, 2023-10, Vol.34, p.S1230-S1230

2023

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort

Annals of oncology, 2018-10, Vol.29, p.viii406-viii406

2018

Volltextzugriff (PDF)

1200P BrigALK2 study: A multicentric real-world study evaluating brigatinib in ALK positive advanced pre-treated non-small cell lung cancers: Long-term follow-up with focus on lorlatinib efficacy after brigatinib

Annals of oncology, 2021-09, Vol.32, p.S958-S958

2021

Volltextzugriff (PDF)

Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis

Journal of the International AIDS Society, 2020-02, Vol.23 (2), p.e25420-n/a

2020

Volltextzugriff (PDF)

Anxiété et performance aux ECOS

La revue de medecine interne, 2023-06, Vol.44, p.A80-A81

2023

Volltextzugriff (PDF)

IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer

Revue des maladies respiratoires, 2018-11, Vol.35 (9), p.983

2018

Volltextzugriff (PDF)

3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience

European journal of cancer (1990), 2015-09, Vol.51, p.S616-S617

2015

Volltextzugriff (PDF)

1392P Brigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Annals of oncology, 2020-09, Vol.31, p.S884-S884

2020

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(90)
Berichte
(1)

Sprache

Englisch
(51)
Französisch
(41)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Male
(23)
Middle Aged
(16)
Adult
(14)
Aged
(14)
Female
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Animals
(8)
Life Sciences
(8)
Respiratory System
(7)
Sciences Biologiques Et Medicales
(7)
Sciences Medicales
(7)
Aged, 80 And Over
(6)
Lung Neoplasms - Pathology
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
France
(5)
Lung Cancer
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency): RNA and DNA analysis

Molecular heterogeneity of McArdle disease

Modifications of aldolase during in vivo aging of rabbit red cells

Characterization of three optional promoters in the 5′ region of the human aldolase A gene

Purification of aldolase C from rat brain and hepatoma

Demonstration of aldolase immunologic cross reaction material (CRM) in rabbit erythrocyte and reticulocyte hemolysates

Expression of aldolase a messenger RNAs in human adult and foetal tissues and in hepatoma

Expression of two aldolase A mRNA species in different human and rat tissues

Phosphofructokinases from foetal and adult human muscles

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Modifications de l' aldolase pendant le vieillissement in vivo des globules rouges du lapin

Molecular aging of fructose-bisphosphate aldolase in tissues of rabbit and man

Molecular aging of fructose-bisphosphate adolase in tissues of rabbit and man

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)

CN15 Real-life clinical and organizational evaluation of telemonitoring and assisted telemonitoring in more than 1500 cancer patients

Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma: Data from a French multicentric cohort

1200P BrigALK2 study: A multicentric real-world study evaluating brigatinib in ALK positive advanced pre-treated non-small cell lung cancers: Long-term follow-up with focus on lorlatinib efficacy after brigatinib

Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate – emtricitabine for HIV pre‐exposure prophylaxis

Anxiété et performance aux ECOS

IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer

3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience

1392P Brigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Suchergebnisse filtern